LRA Announces Inaugural Awards Promoting Diversity in Lupus Research
NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research, today announced inaugural recipients of Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Award funding mechanisms aim to address underrepresentation of minorities in the scientific research profession. Lupus […]
Lupus Research Alliance Announces 10 Recipients of New Award in Partnership with Bristol Myers Squibb
NEW YORK, NY. July 14, 2020 — The Lupus Research Alliance (LRA) is pleased to announce the recipients of the inaugural LRA-BMS Accelerator Award*, a collaborative project with sponsoring partner Bristol Myers Squibb. The Award provides a collective total of $3,000,000 to support ten cutting-edge lupus research projects over two years that focus on […]
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly encouraged by the positive results reported for several potential new treatments that may help people with lupus. “The foundational work the Lupus Research Alliance and others have supported is beginning to bear fruit with potential […]
2018 Distinguished Innovator Awardees Named by Lupus Research Alliance
NEW YORK, NY. December 20. The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Nir Hacohen, PhD (right) and Vijay Kuchroo, DVM, PhD (left). Dr. Hacohen is seeking better ways to treat lupus kidney disease, the major cause of illness and […]
Promising New Lupus Treatments Highlighted ACR Annual Meeting
Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […]
New Treatment Approaches Supported by LRA Were Highlighted at LUPUS 2019
April 11, 2019 The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has shown promising results in research models—these are just some of the findings presented by Lupus Research Alliance-funded scientists at the 13th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), held in San Francisco. Here are […]
2022 New Jersey Walk with Us to Cure Lupus Raises Awareness and Funds for Commonly Misdiagnosed Autoimmune Disease
May 14, 2022 EAST RUTHERFORD, NEW JERSEY. May 14, 2022. The Lupus Research Alliance (LRA) brought together thousands of people to MetLife Stadium for the 2022 New Jersey Walk with Us to Cure Lupus to raise lupus awareness. The MetLife walk marked the 20th anniversary of the LRA’s national Walk Program. As Honorary Chair of […]
Lupus Research Alliance Welcomes Voclosporin Trial Results
First Promising Phase II Data in Lupus Nephritis NEW YORK, NY — The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase II study of a greatly needed potential treatment for lupus nephritis. Up to 60% of people with lupus develop lupus nephritis, a devastating complication that can cause kidney failure and […]
Lupus Research Alliance Announces 2022 Dr. William E. Paul Distinguished Innovator Awards Investigating Harmful Immune T Cells
NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the 2022 Dr. William E. Paul Distinguished Innovator Award (DIA): Hongbo Chi, PhD, and Joseph Craft, MD. Both awards are focused on studying distinct T cell populations in lupus which aligns with LRA’s strategic objective to accelerate […]
Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammation
Research Published in Nature Communications and Funded in Part by the Lupus Research Alliance Could Correct a Defect in Lupus NEW YORK, NY. February 6. Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious and potentially […]